Louisiana’s Mail-Order Abortion Lawsuit Paused But “Likely To Succeed”

LAFAYETTE, LA – A federal judge temporarily halted Louisiana’s lawsuit against the U.S. Food and Drug Administration (FDA) seeking to limit access to the dangerous chemical abortion drug Mifepristone’s mail-order availability while the agency completes an ongoing safety review of the drug. While the pause keeps mail dispensing of chemical abortion drugs in place for now, the judge noted that Louisiana Attorney General Liz Murrill, and Rosalie Markezich, who was coerced by her boyfriend to have an abortion via mail-order pills, have standing to bring the lawsuit. The judge ruled that the state and Markezich “are likely to succeed on the merits” due to the FDA’s “own shortcomings” in loosening the drug’s safety restrictions.